MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 199 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,669,421 | -36.9% | 18,300 | 0.0% | 0.90% | -30.1% |
| Q2 2023 | $4,227,300 | +1114.7% | 18,300 | +242.1% | 1.29% | +1049.1% |
| Q3 2022 | $348,000 | -93.5% | 5,350 | +1296.9% | 0.11% | +100.0% |
| Q2 2022 | $5,350,000 | +5.6% | 383 | -92.8% | 0.06% | -95.1% |
| Q1 2022 | $5,066,000 | +208.7% | 5,350 | -46.5% | 1.14% | +46.4% |
| Q3 2018 | $1,641,000 | -41.2% | 10,000 | 0.0% | 0.78% | -27.2% |
| Q2 2018 | $2,790,000 | +21.7% | 10,000 | -60.0% | 1.07% | +32.5% |
| Q4 2017 | $2,293,000 | – | 25,000 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |